{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T21:04:52Z","timestamp":1790629492035,"version":"4.1.0"},"reference-count":26,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2007,1,1]],"date-time":"2007-01-01T00:00:00Z","timestamp":1167609600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Gynecologic Oncology"],"published-print":{"date-parts":[[2007,1]]},"DOI":"10.1016\/j.ygyno.2006.06.039","type":"journal-article","created":{"date-parts":[[2006,9,7]],"date-time":"2006-09-07T09:12:45Z","timestamp":1157620365000},"page":"41-45","source":"Crossref","is-referenced-by-count":48,"title":["Isolated lymph node relapse of epithelial ovarian carcinoma: Outcomes and prognostic factors"],"prefix":"10.1016","volume":"104","author":[{"given":"Pierre","family":"Blanchard","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne","family":"Plantade","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C\u00e9cile","family":"Pag\u00e8s","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pauline","family":"Afchain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christophe","family":"Louvet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christophe","family":"Tournigand","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aimery","family":"de Gramont","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ygyno.2006.06.039_bib1","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1023\/A:1008240421028","article-title":"Predictors of response to subsequent chemotherapy in platinum pretreated ovarian cancer: a multivariate analysis of 704 patients","volume":"10","author":"Eisenhauer","year":"1997","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.ygyno.2006.06.039_bib2","doi-asserted-by":"crossref","first-page":"2519","DOI":"10.1056\/NEJMra041842","article-title":"Cancer of the ovary","volume":"351","author":"Cannistra","year":"2004","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ygyno.2006.06.039_bib3","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1200\/JCO.2002.20.5.1161","article-title":"Recurrent ovarian cancer: evidence-based treatment","volume":"20","author":"Ozols","year":"2002","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.ygyno.2006.06.039_bib4","doi-asserted-by":"crossref","first-page":"1561","DOI":"10.1002\/1097-0142(19871001)60:7<1561::AID-CNCR2820600725>3.0.CO;2-V","article-title":"Distant metastases in epithelial ovarian carcinoma","volume":"60","author":"Dauplat","year":"1987","journal-title":"Cancer"},{"key":"10.1016\/j.ygyno.2006.06.039_bib5","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1046\/j.1525-1438.2003.13054.x","article-title":"Distant metastases in ovarian carcinoma","volume":"13","author":"Cormio","year":"2003","journal-title":"Int. J. Gynecol. Cancer"},{"key":"10.1016\/j.ygyno.2006.06.039_bib6","doi-asserted-by":"crossref","first-page":"S134","DOI":"10.1006\/gyno.1994.1352","article-title":"Follow-up of the asymptomatic patient with ovarian cancer","volume":"55","author":"Markman","year":"1994","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.ygyno.2006.06.039_bib7","first-page":"833","article-title":"Salvage therapy for ovarian cancer","volume":"12","author":"Sabbatini","year":"1998","journal-title":"Oncology (Willist. Park)"},{"key":"10.1016\/j.ygyno.2006.06.039_bib8","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1200\/JCO.1991.9.3.389","article-title":"Second-line platinum therapy in patients with ovarian cancer previously treated with cisplatin","volume":"9","author":"Markman","year":"1991","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.ygyno.2006.06.039_bib9","doi-asserted-by":"crossref","first-page":"1764","DOI":"10.1016\/0959-8049(94)E0125-N","article-title":"Response to second-line weekly cisplatin chemotherapy in ovarian cancer previously treated with a cisplatin- or carboplatin-based regimen","volume":"30A","author":"Bolis","year":"1994","journal-title":"Eur. J. Cancer"},{"key":"10.1016\/j.ygyno.2006.06.039_bib10","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/0090-8258(90)90174-J","article-title":"Treatment of relapsed carcinoma of the ovary with cisplatin or carboplatin following initial treatment with these compounds","volume":"36","author":"Gore","year":"1990","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.ygyno.2006.06.039_bib11","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/0277-5379(91)90507-A","article-title":"Carboplatin and cyclophosphamide salvage therapy for ovarian cancer patients relapsing after cisplatin combination chemotherapy","volume":"27","author":"van der Burg","year":"1991","journal-title":"Eur. J. Cancer"},{"issue":"Suppl. 1","key":"10.1016\/j.ygyno.2006.06.039_bib12","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/S0020-7292(03)90118-4","article-title":"Carcinoma of the ovary","volume":"83","author":"Heintz","year":"2003","journal-title":"Int. J. Gynaecol. Obstet."},{"key":"10.1016\/j.ygyno.2006.06.039_bib13","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.1002\/(SICI)1097-0142(19981015)83:8<1555::AID-CNCR10>3.0.CO;2-R","article-title":"Patients with ovarian carcinoma upstaged to stage III after systematic lymphadenectomy have similar survival to Stage I\/II patients and superior survival to other Stage III patients","volume":"83","author":"Onda","year":"1998","journal-title":"Cancer"},{"key":"10.1016\/j.ygyno.2006.06.039_bib14","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1093\/jnci\/dji102","article-title":"Systematic aortic and pelvic lymphadenectomy versus resection of bulky nodes only in optimally debulked advanced ovarian cancer: a randomized clinical trial","volume":"97","author":"Panici","year":"2005","journal-title":"J. Natl. Cancer Inst."},{"key":"10.1016\/j.ygyno.2006.06.039_bib15","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/0090-8258(91)90099-Q","article-title":"Patterns of pelvic and paraaortic lymph node involvement in ovarian cancer","volume":"40","author":"Burghardt","year":"1991","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.ygyno.2006.06.039_bib16","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/S0046-8177(88)80316-2","article-title":"Distribution of disease at autopsy in 100 women with ovarian cancer","volume":"19","author":"Dvoretsky","year":"1988","journal-title":"Hum. Pathol."},{"key":"10.1016\/j.ygyno.2006.06.039_bib17","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1006\/gyno.1993.1177","article-title":"Ovarian carcinoma presenting with inguinal metastatic lymphadenopathy 33\u00a0months prior to intraabdominal disease","volume":"50","author":"Kehoe","year":"1993","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.ygyno.2006.06.039_bib18","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1006\/gyno.1999.5592","article-title":"Inguinal lymph node metastasis as the only manifestation of lymphatic spread in ovarian cancer: a case report","volume":"75","author":"Scholz","year":"1999","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.ygyno.2006.06.039_bib19","first-page":"189","article-title":"Ovarian carcinoma metastatic to bilateral axillary lymph nodes. A case report","volume":"20","author":"Orris","year":"1999","journal-title":"Eur. J. Gynaecol. Oncol."},{"key":"10.1016\/j.ygyno.2006.06.039_bib20","doi-asserted-by":"crossref","first-page":"1646","DOI":"10.1097\/00000478-200412000-00015","article-title":"Serous carcinoma of the ovary and peritoneum with metastases to the breast and axillary lymph nodes: a potential pitfall","volume":"28","author":"Recine","year":"2004","journal-title":"Am. J. Surg. Pathol."},{"key":"10.1016\/j.ygyno.2006.06.039_bib21","first-page":"1471","article-title":"Solitary parenchymal splenic recurrence of ovarian adenocarcinoma: a case report and review of the literature","volume":"25","author":"Tserkezoglou","year":"2005","journal-title":"Anticancer Res."},{"key":"10.1016\/j.ygyno.2006.06.039_bib22","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1245\/ASO.2004.11.023","article-title":"Outcomes after combined therapy including surgical resection in patients with epithelial ovarian cancer recurrence(s) exclusively in lymph nodes","volume":"11","author":"Uzan","year":"2004","journal-title":"Ann. Surg. Oncol."},{"key":"10.1016\/j.ygyno.2006.06.039_bib23","first-page":"169","article-title":"Are nodal metastases in ovarian cancer chemoresistant lesions? Analysis of nodal involvement in 105 patients treated with preoperative chemotherapy","volume":"25","author":"Morice","year":"2004","journal-title":"Eur. J. Gynaecol. Oncol."},{"key":"10.1016\/j.ygyno.2006.06.039_bib24","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1006\/gyno.1998.5074","article-title":"Factors predictive of survival after first relapse or progression in advanced epithelial ovarian carcinoma: a prediction tree analysis-derived model with test and validation groups","volume":"70","author":"Hoskins","year":"1998","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.ygyno.2006.06.039_bib25","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/S1072-7515(03)00234-5","article-title":"Lymph node involvement in epithelial ovarian cancer: analysis of 276 pelvic and paraaortic lymphadenectomies and surgical implications","volume":"197","author":"Morice","year":"2003","journal-title":"J. Am. Coll. Surg."},{"key":"10.1016\/j.ygyno.2006.06.039_bib26","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1177\/107327480501200403","article-title":"Cutaneous melanoma: prognostic factors","volume":"12","author":"Homsi","year":"2005","journal-title":"Cancer Control"}],"container-title":["Gynecologic Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090825806005373?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090825806005373?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,4,20]],"date-time":"2019-04-20T22:26:22Z","timestamp":1555799182000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0090825806005373"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,1]]},"references-count":26,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2007,1]]}},"alternative-id":["S0090825806005373"],"URL":"https:\/\/doi.org\/10.1016\/j.ygyno.2006.06.039","relation":{},"ISSN":["0090-8258"],"issn-type":[{"value":"0090-8258","type":"print"}],"subject":[],"published":{"date-parts":[[2007,1]]}}}